HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seiji Kojima Selected Research

Exanthema (Rash)

1/2021Successful treatment of a novel type I interferonopathy due to a de novo PSMB9 gene mutation with a Janus kinase inhibitor.
4/2002Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seiji Kojima Research Topics

Disease

38Aplastic Anemia (Anemia, Hypoplastic)
08/2021 - 04/2003
18Infections
10/2023 - 01/2002
13Neoplasms (Cancer)
04/2024 - 02/2006
10Leukemia
04/2024 - 04/2003
10Juvenile Myelomonocytic Leukemia
01/2019 - 10/2006
9Graft vs Host Disease (Graft-Versus-Host Disease)
07/2023 - 02/2006
9Diamond-Blackfan Anemia (Anemia, Diamond Blackfan)
05/2021 - 01/2004
8Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2018 - 12/2007
6Cytopenia
11/2020 - 11/2015
6Anemia
11/2020 - 05/2003
6Disease Progression
11/2020 - 03/2002
6Bone Marrow Failure Disorders
01/2020 - 07/2008
6Epstein-Barr Virus Infections
09/2013 - 09/2004
5Down Syndrome (Down's Syndrome)
10/2020 - 10/2003
5Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita)
06/2020 - 03/2011
5Hematologic Neoplasms (Hematological Malignancy)
08/2018 - 12/2008
5Hypersensitivity (Allergy)
11/2014 - 07/2008
4Neutropenia
05/2011 - 09/2008
3Neuroblastoma
01/2022 - 02/2011
3Pulmonary Hypertension
01/2021 - 09/2015
3Fanconi Anemia (Fanconi's Anemia)
12/2020 - 06/2012
3Chromosome Aberrations (Chromosome Abnormalities)
11/2020 - 07/2002
3Inflammation (Inflammations)
11/2018 - 01/2008
3Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
08/2016 - 10/2013
3Hepatitis
12/2015 - 12/2007
3Pathologic Complete Response
09/2014 - 04/2003
3Leukocytosis (Pleocytosis)
08/2012 - 06/2007
3Viremia
09/2008 - 01/2002
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2007 - 01/2004
2Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
11/2022 - 01/2018
2Uniparental Disomy
01/2022 - 04/2010
2Exanthema (Rash)
01/2021 - 04/2002
2Pulmonary Arterial Hypertension
01/2021 - 09/2015
2Flushing
01/2021 - 12/2020
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2020 - 12/2009
2Supravalvular Aortic Stenosis (Aortic Supravalvular Stenosis)
10/2019 - 01/2019
2Granuloma
01/2019 - 01/2018
2Primary Immunodeficiency Diseases
01/2019 - 12/2016
2Pulmonary Fibrosis (Fibrosing Alveolitis)
11/2016 - 10/2010
2Hematologic Diseases (Blood Diseases)
12/2015 - 02/2006
2monosomy Chromosome 7
11/2015 - 11/2014
2Congenital Bone Marrow Failure Syndromes
03/2015 - 01/2013
2Hemorrhagic Cystitis
02/2015 - 03/2010
2Lymphoma (Lymphomas)
01/2015 - 06/2011
2Blast Crisis (Blast Phase)
11/2014 - 06/2014
2Sepsis (Septicemia)
08/2014 - 07/2006
2Persistent Infection
01/2014 - 09/2013

Drug/Important Bio-Agent (IBA)

16Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
07/2023 - 04/2003
15Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2019 - 04/2003
6AutoantibodiesIBA
01/2021 - 12/2003
6Proteins (Proteins, Gene)FDA Link
01/2021 - 05/2006
6DNA (Deoxyribonucleic Acid)IBA
10/2020 - 01/2002
6Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
11/2014 - 07/2008
5Melphalan (Alkeran)FDA LinkGeneric
01/2022 - 12/2008
5Biomarkers (Surrogate Marker)IBA
12/2016 - 09/2013
4HLA Antigens (Human Leukocyte Antigens)IBA
07/2023 - 09/2004
4Etoposide (VP 16)FDA LinkGeneric
01/2022 - 04/2003
4AldehydesIBA
12/2020 - 02/2015
4Rituximab (Mabthera)FDA Link
10/2020 - 09/2009
4fludarabineIBA
01/2020 - 12/2008
4thymoglobulinFDA Link
01/2019 - 01/2013
4Ribosomal Proteins (Ribosomal Protein)IBA
04/2017 - 08/2010
3EnzymesIBA
12/2020 - 06/2015
3Telomerase (Telomerase Reverse Transcriptase)IBA
06/2020 - 05/2006
3Membrane Proteins (Integral Membrane Proteins)IBA
11/2019 - 09/2004
3SteroidsIBA
01/2019 - 12/2016
3CytokinesIBA
08/2016 - 02/2005
3Tacrolimus (Prograf)FDA LinkGeneric
08/2014 - 06/2007
3Immunoglobulin G (IgG)IBA
10/2013 - 02/2005
3Cytarabine (Cytosar-U)FDA LinkGeneric
09/2012 - 12/2007
3Methotrexate (Mexate)FDA LinkGeneric
12/2009 - 06/2007
3AntigensIBA
10/2006 - 12/2003
2Messenger RNA (mRNA)IBA
04/2024 - 10/2012
2NucleotidesIBA
05/2023 - 01/2013
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2022 - 10/2009
2Formaldehyde (Formol)FDA Link
01/2021 - 12/2020
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
10/2020 - 03/2008
2MicroRNAs (MicroRNA)IBA
10/2020 - 09/2013
2Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
10/2020 - 03/2006
2Immunoglobulins (Immunoglobulin)IBA
10/2020 - 02/2015
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2020 - 04/2003
2ElastinIBA
10/2019 - 01/2019
2Silver NitrateIBA
01/2019 - 01/2018
2Phosphotransferases (Kinase)IBA
01/2018 - 12/2009
2Danazol (Azol)FDA LinkGeneric
11/2016 - 06/2011
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2016 - 09/2015
2HydrogenIBA
01/2016 - 09/2015
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2015 - 06/2005
2AntibodiesIBA
10/2013 - 01/2005

Therapy/Procedure

31Hematopoietic Stem Cell Transplantation
10/2023 - 01/2004
24Transplantation
07/2023 - 04/2002
24Therapeutics
01/2021 - 07/2002
17Bone Marrow Transplantation (Transplantation, Bone Marrow)
07/2023 - 03/2002
9Stem Cell Transplantation
10/2018 - 02/2008
8Drug Therapy (Chemotherapy)
01/2022 - 06/2007
3Cell Transplantation
12/2014 - 02/2006
3Aftercare (After-Treatment)
11/2014 - 06/2005
2Combination Drug Therapy (Combination Chemotherapy)
01/2022 - 04/2003
2Chemoradiotherapy
10/2015 - 05/2009
2Blood Transfusion (Blood Transfusions)
08/2014 - 01/2013